Exchange: NYSE·Updated 07:48 PM EST
HCA logo

HCA HCA Healthcare Inc

$511.78
$12.73
(2.55%)
Today
Closed $511.78
$2.80
(0.55%)
After Hours
Reported EarningsOct 27
Mkt Cap$104.25B
Vol1.06M

About HCA

HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
41

Bearish Sentiment

How do you feel about HCA?

topstockalerts
HCA Healthcare shares surged approximately 10% after Democrats secured control of both chambers of Congress in the U.S. midterm elections, while President Trump indicated he would accept the results, reducing political uncertainty and boosting healthcare stocks. Bernstein analysts noted that a Democrat-controlled Congress could benefit Medicaid and ACA insurers as well as hospital operators, potentially through bipartisan compromise legislation similar to the late-1990s Clinton-era political dynamics under a Republican White House. Adding to the momentum, Truist Securities reaffirmed its Buy rating on HCA and raised its price target from $495 to $510, providing additional analyst support ahead of the rally. HCA also filed a 424B5 prospectus confirming the pricing of a senior notes offering tied to its plan to refinance $1.2B in debt maturing in early 2027, highlighting proactive balance-sheet management. $HCA
ClaxtonGenZ
$HCA hope the people making important decisions understand how much their choices matter
KryptonResearch14
$HCA Q3 adjusted EPS was 7.22 dollars, ahead of the 6.63 to 6.75 dollars expected, on revenue of 19.85 billion dollars, up 3.6%. That print absorbed an estimated 400 million dollar pretax hit from a payer mix shift toward uninsured patients. The volume mix is kinda odd though. Same facility ER visits rose 5.1% and admissions rose 2.7%, but inpatient surgeries fell 1.4% and outpatient surgeries fell 3.7%, and revenue per equivalent admission rose just 0.6%. Net income actually fell 3.9% to 1.58 billion dollars. The EPS growth came from buybacks, 2.97 billion dollars in the quarter, and management now expects the full year in the upper half of its guidance ranges.
shoc24
$HCA Reported today: EPS of $7.22 vs. $6.65 expected (+8.6%, beat). Revenue of $19.8B vs. $19.3B expected (+2.7%, beat). I used Stock Meadow’s earnings dashboard to review the results.
shoc24
$HCA Reported today: EPS of $7.22 vs. $6.65 expected (+8.6%, beat). Revenue of $19.8B vs. $19.3B expected (+2.7%, beat). I used Stock Meadow’s earnings dashboard to review the results.
filecrux
$HCA Can HCA reach the upper half of its 2026 guidance after uninsured patients cost it about $400M in Q3? 🏢 HCA Healthcare runs 189 hospitals and about 2,600 outpatient sites in 19 states and the UK, and it was worth about $103.21B at $465.26 a share at 16:00 ET on October 26, 2026 🚀 HCA's Q3 release says full-year 2026 results should land in the upper half of the ranges it set on July 14: diluted EPS of $28.70–$30.50, Adjusted EBITDA of $15.4B–$16.1B and revenue of $77.0B–$79.5B ⚠️ The upper half needs at least $29.60 of full-year EPS, the range midpoint, or about $7.63 in Q4 after $21.97 adjusted through nine months, above Q3's adjusted $7.22 📈 On the other side, same-facility equivalent admissions rose 3.0% and ER visits rose 5.1%, partly from uninsured patients 📅 Next: Management walks investors through the quarter on today's call, and holders of record on December 15, 2026 get a $0.78 dividend paid December 29, 2026 Source: SEC 8-K and Q3 release, Oct 27
StocktwitsEarnings
$HCA Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $7.22 up 3.74% YoY • Reported revenue of $19.85B up 3.59% YoY • HCA Healthcare believes 2026 results will be in the upper half of prior guidance: $77B, $6.3B, $15.4B, diluted EPS $28.70-$30.50.
KryptonResearch14
$HCA reports Tuesday before the open, and the range here is pretty wide. Consensus is sitting around 6.63 to 6.75 dollars of EPS on roughly 19.3 to 19.4 billion dollars of revenue, but the EPS range runs 5.83 to 7.35 dollars and that consensus has been cut 5.3% in 90 days, from 7.00 dollars. Zacks also has revenue per equivalent admission slipping to about 18,270 dollars, from 18,446 dollars a year ago. Volumes look fine, pricing per admission is drifting down a bit.

Advertisement|Remove ads.